{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-012536","form_type":"8-K","ticker":"SHPH","cik":"0001757499","company_name":"Shuttle Pharmaceuticals Holdings, Inc.","filed_at":"2025-05-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.603656+00:00","generated_at":"2026-05-20T08:22:44.880644+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Shuttle Pharmaceuticals implements 70% salary reduction for all salaried employees, including named executive officers","bullets":["Effective May 21, 2025, all salaried employees and named executive officers face a 70% salary reduction.","Affected executives: Interim CEO Christopher Cooper, COO Peter Dritschilo, CSO Mira Jung, CCO Tyvin Rich, VP Regulatory Michael P. Vander Hoek.","CFO Timothy Lorber's 70% salary reduction is deferred and will be paid later, unlike the outright reduction for others.","The salary cuts reflect a significant cost-reduction measure amid apparent financial pressures."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-012536","json":"https://secwatch.observer/filing/0001641172-25-012536.json","markdown":"https://secwatch.observer/filing/0001641172-25-012536.md","text":"https://secwatch.observer/filing/0001641172-25-012536.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1757499/000164117225012536/0001641172-25-012536-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1757499/000164117225012536/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T08:22:44.880644+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}